Jason Baum
Hoofd Techniek/Wetenschap/O&O bij LEAP THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Jason Baum
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 17 | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jason Baum via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Founder | |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Adheron Therapeutics, Inc.
 Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member President Director/Board Member | |
Veridex LLC
 Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Medical Specialties | Sales & Marketing | |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| Boston University | College/University | Corporate Officer/Principal Masters Business Admin | |
| The University of Chicago | College/University | Corporate Officer/Principal Undergraduate Degree | |
| St. Joseph's University | College/University | Masters Business Admin | |
| University of Louisiana at Lafayette | College/University | Undergraduate Degree | |
| University College Dublin | College/University | Undergraduate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Chief Executive Officer | |
Healthcare Ventures VII LP
 Healthcare Ventures VII LP Investment ManagersFinance HealthCare Ventures VII LP seeks investment opportunities in life science companies located in the US with an annual revenues ranging from $50 - $100 million. The fund targets companies operating in the fields of cancer therapy, infectious diseases, cardiovascular diseases, central nervous system disorders, immunotherapy, novel manufacturing technologies and novel lab scale instruments & reagents. It provides financing in the form of equity and debt convertible to equity for early and later stage capital requirements with an investment size of $1,000,000 - $20,000,000. It also makes investments in both private and public companies. | Investment Managers | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | President President | |
| Healthcare Pharmaceuticals, Inc. (Utah) | Director/Board Member Director/Board Member | ||
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Serono Corp. | Corporate Officer/Principal | ||
New England Journal of Medicine
 New England Journal of Medicine Packaged SoftwareTechnology Services The New England Journal of Medicine develops medical software. | Packaged Software | Corporate Officer/Principal | |
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Friends of Cancer Research
 Friends of Cancer Research Miscellaneous Commercial ServicesCommercial Services Friends of Cancer Research operates an organization focused on healthcare development. The non-profit company is based in Arlington, VA. The company was founded by Ellen V. Sigal. | Miscellaneous Commercial Services | Director/Board Member | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Vaxxas Pty Ltd.
 Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Medical Specialties | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Chief Executive Officer | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member | |
| The University of Michigan Law School | College/University | Graduate Degree | |
| Pritzker School of Medicine | College/University | Doctorate Degree | |
Healthcare Strategic Partners, LLC
 Healthcare Strategic Partners, LLC Medical/Nursing ServicesHealth Services Part of HealthCare Ventures LLC, Healthcare Strategic Partners, LLC is an American company that provides healthcare services. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| UroGen Pharma, Inc. | Biotechnology | Chief Executive Officer | |
WIN Consortium
 WIN Consortium Miscellaneous Commercial ServicesCommercial Services WIN Consortium is a French company that researches and develops cancer medicine. The company is based in Villejuif, France. The company was founded in 2010 by Vladimir Lazar. | Miscellaneous Commercial Services | Chairman | |
| Healthcare Partners IX LLC | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Zwitserland | 3 |
| Ierland | 2 |
| Israël | 2 |
| Australië | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 10 |
| Finance | 4 |
| Commercial Services | 4 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 162 |
| Corporate Officer/Principal | 75 |
| Independent Dir/Board Member | 39 |
| President | 35 |
| Chairman | 24 |
Sterkste connecties
| Insiders | |
|---|---|
| Augustine Lawlor | 43 |
| James Cavanaugh | 38 |
| Chris Mirabelli | 29 |
| Doug Onsi | 25 |
| Joseph Loscalzo | 25 |
| Thomas Dietz | 21 |
| Patricia Martin | 21 |
| Elizabeth Barrett | 14 |
| Monica Bertagnolli | 14 |
| Susanne Antonie Schaffert | 13 |
| Nissim Mashiach | 11 |
| Bruno Strigini | 10 |
| William Li | 10 |
| Ameet Mallik | 10 |
| Richard Schilsky | 9 |
- Beurs
- Insiders
- Jason Baum
- Bedrijfsconnecties
